ArticleScientific reports2025
Phytochemical and bioactive insights into endophytic fungi from Wrightia tinctoria with emphasis on Xylaria rohrensis metabolites potential.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- In Vitro Modeling of Mycelium Biomass Growth Kinetics of the Novel Fungicolous SpeciesJournal of fungi (Basel, Switzerland) · 2026Article
- Bioactivity screening of endophytic fungi from Sterculia urens and GC-MS metabolites profiling of the potent isolate Chaetomium meridiolense.Scientific reports · 2026Article
- Bioprospecting endophytic fungi,Science progressArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endophytic fungi represent a prolific reservoir of bioactive compounds with potential therapeutic and biotechnological applications. In this study, nine endophytic fungi were isolated from healthy plant parts of the medicinal plant Wrightia tinctoria and evaluated for their phytochemical profiles, antioxidant properties, and antibacterial activities. Among them, Xylaria rohrensis consistently exhibited the strongest bioactivity, with high levels of phenolic and flavonoid contents, correlating with strong antioxidant activity and growth inhibition of both Gram-positive and Gram-negative bacteria. Based on these results, X. rohrensis was selected for further chemical characterization. Fourier-transform infrared (FTIR) spectroscopy revealed prominent absorption bands corresponding to hydroxyl, carbonyl, and aromatic functional groups, confirming the presence of phenolic and flavonoid compounds. Gas chromatography-mass spectrometry (GC-MS) analysis identified a diverse array of secondary metabolites, including phenolic derivatives, sterols, and fatty acids, several of which are known for their antioxidant and antimicrobial properties. To our knowledge, this is the first detailed report describing the metabolite composition and biological potential of X. rohrensis as an endophyte. Multivariate analyses, including principal component analysis (PCA) and correlation studies, demonstrated clear associations between metabolite abundance and biological activity. These findings highlight X. rohrensis as a promising source of novel natural products and expand our understanding of the functional roles of endophytic fungi in medicinal plants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.